Put Options

14 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 09, 2024

BUY
$61.03 - $69.57 $5.98 Million - $6.82 Million
98,000 New
98,000 $6.64 Million
Q2 2022

Aug 11, 2022

SELL
$59.26 - $71.14 $100 Million - $120 Million
-1,693,600 Closed
0 $0
Q1 2022

May 11, 2022

BUY
$55.72 - $67.12 $57.6 Million - $69.4 Million
1,033,400 Added 156.53%
1,693,600 $112 Million
Q4 2021

Feb 10, 2022

SELL
$54.02 - $63.83 $36.7 Million - $43.3 Million
-678,600 Reduced 50.69%
660,200 $38.5 Million
Q3 2021

Nov 12, 2021

BUY
$55.56 - $60.79 $16.7 Million - $18.3 Million
301,100 Added 29.02%
1,338,800 $80.4 Million
Q2 2021

Aug 12, 2021

BUY
$48.42 - $60.18 $33.5 Million - $41.7 Million
692,100 Added 200.26%
1,037,700 $62.2 Million
Q1 2021

May 17, 2021

BUY
$47.16 - $54.44 $11.6 Million - $13.4 Million
245,900 Added 246.64%
345,600 $17.2 Million
Q3 2020

Nov 13, 2020

BUY
$53.07 - $61.1 $5.29 Million - $6.09 Million
99,700 New
99,700 $5.46 Million
Q1 2020

May 13, 2020

SELL
$37.79 - $51.33 $604,640 - $821,280
-16,000 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$42.46 - $50.46 $3.6 Million - $4.27 Million
-84,700 Reduced 84.11%
16,000 $798,000
Q3 2018

Nov 09, 2018

BUY
$34.76 - $39.72 $1.03 Million - $1.18 Million
29,600 Added 41.63%
100,700 $3.99 Million
Q1 2018

May 09, 2018

SELL
$32.97 - $36.63 $6.35 Million - $7.05 Million
-192,600 Reduced 73.04%
71,100 $2.49 Million
Q4 2017

Feb 09, 2018

SELL
$32.09 - $34.78 $17.8 Million - $19.3 Million
-554,400 Reduced 67.77%
263,700 $9.15 Million
Q3 2017

Nov 13, 2017

BUY
$28.96 - $34.0 $23.7 Million - $27.8 Million
818,100
818,100 $27.7 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $208B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Twin Tree Management, LP Portfolio

Follow Twin Tree Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Twin Tree Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Twin Tree Management, LP with notifications on news.